Key result
Endomyocardial biopsy remains the gold standard to guide immunosuppression in inflammatory cardiomyopathy.
This review provides a comprehensive overview of the pathophysiology, diagnostic modalities including MRI and endomyocardial biopsy, and therapeutic strategies for inflammatory cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Endomyocardial biopsy guides immunosuppression in inflammatory cardiomyopathy; leaves open randomized validation of targeted regimens.
Krejčí et al. (2016) conducted a review in Inflammatory cardiomyopathy and myocarditis. Diagnosis and management of inflammatory cardiomyopathy was evaluated. Inflammatory cardiomyopathy is primarily managed with standard heart failure therapy, while endomyocardial biopsy remains the gold standard for diagnosis and guiding specific immunosuppressive treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: